To evaluate the efficacy of ALK-001 compared with placebo in slowing the progression of retinal atrophic lesion growth in participants with STGD
In this study we want to gather information about Stargardt Disease Type 1 (STGD1) and learn how it develops over time. We hope to use this information to help scientists come up with treatments or a cure for STGD1 in the future.